About N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide
N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide (PubChem CID 164547238) has the molecular formula C51H54N16O5S2
and a molecular weight of 1035.23 g/mol. Its IUPAC name is N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide.
Frequently Asked Questions
What is the IUPAC name of N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The IUPAC name of N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide (CID 164547238) is N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide.
What is the SMILES notation for N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The canonical SMILES for N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide is Cc1ncc(C(=O)NCCN2CCCC23COC3)cc1NC(=O)c1cnn2cc(-c3cn(CCc4nn(C)cc4-c4cn5nc6c7ncc(C(=O)NCCN8CCC9(CC9)C8)cc7[nH]c(=O)c6c5s4)nc3C)sc12.
What is the InChIKey of N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
The InChIKey is CHQIHDJSUUESCJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C51H54N16O5S2/c1-29-34(39-24-66-48(73-39)33(21-56-66)46(70)57-37-17-31(19-54-30(37)2)44(68)53-11-16-64-12-4-6-51(64)27-72-28-51)23-65(59-29)13-5-36-35(22-62(3)60-36)40-25-67-49(74-40)41-43(61-67)42-38(58-47(41)71)18-32(20-55-42)45(69)52-10-15-63-14-9-50(26-63)7-8-50/h17-25H,4-16,26-28H2,1-3H3,(H,52,69)(H,53,68)(H,57,70)(H,58,71).
What are the key properties of N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide?
N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide has a molecular weight of 1035.23 g/mol, XLogP of 5.08, 15 rotatable bonds, 4 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(5-azaspiro[2.4]heptan-5-yl)ethyl]-13-[1-methyl-3-[2-[3-methyl-4-[7-[[2-methyl-5-[2-(2-oxa-5-azaspiro[3.4]octan-5-yl)ethylcarbamoyl]-3-pyridinyl]carbamoyl]pyrazolo[5,1-b][1,3]thiazol-2-yl]pyrazol-1-yl]ethyl]pyrazol-4-yl]-9-oxo-12-thia-3,8,15,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1(16),2(7),3,5,10,13-hexaene-5-carboxamide is sourced from PubChem (CID 164547238), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).